---
layout: post
categories: research
suptitle: Chemo doesn't boost TMB (much)
title:  "Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer"
date: 2018-01-22
venue: BMC Cancer
image: /images/aocs.jpg
paper: https://doi.org/10.1186/s12885-017-3825-0
authors: "<u>Oâ€™Donnell T</u>, Christie EL, Ahuja A, Buros J, Aksoy BA, Bowtell D, Snyder A, Hammerbacher J"
highlight: false
pdf: https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-017-3825-0.pdf
---
Relapsed ovarian cancers harbor more predicted neoantigens than primary tumors,
but the increase is due to pre-existing mutational processes, not mutagenesis
from chemotherapy.

